Does INIPARIB Cause Thrombocytopenia? 16 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 16 reports of Thrombocytopenia have been filed in association with INIPARIB. This represents 44.4% of all adverse event reports for INIPARIB.
16
Reports of Thrombocytopenia with INIPARIB
44.4%
of all INIPARIB reports
0
Deaths
16
Hospitalizations
How Dangerous Is Thrombocytopenia From INIPARIB?
Of the 16 reports, 16 (100.0%) required hospitalization.
Is Thrombocytopenia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for INIPARIB. However, 16 reports have been filed with the FAERS database.
What Other Side Effects Does INIPARIB Cause?
Anaemia (16)
Malignant neoplasm progression (15)
Disease progression (10)
Invasive ductal breast carcinoma (10)
Metastases to bone marrow (10)
Product use in unapproved indication (10)
Bone marrow infiltration (6)
What Other Drugs Cause Thrombocytopenia?
DEXAMETHASONE (5,873)
RITUXIMAB (4,810)
CYCLOPHOSPHAMIDE (4,669)
LENALIDOMIDE (4,584)
CARBOPLATIN (4,483)
METHOTREXATE (3,865)
DOXORUBICIN (3,638)
ETOPOSIDE (3,085)
VINCRISTINE (2,940)
OXALIPLATIN (2,886)